Viragen Inc.

Viragen Inc. went out of business. Viragen Inc. develops, manufactures, and commercializes therapeutic proteins for the treatment of cancers and viral diseases in humans. Its products and product candidate portfolio includes Multiferon, a human alpha interferon product that comprise multiple subtype alpha interferons for the treatment of infectious diseases and cancers; VG101 a therapeutic humanized monoclonal antibody targeting the treatment of malignant melanoma; and VG102 a therapeutic humanized antibody designed for the treatment of various solid tumors. The company also develops Avian Transgenics technology for production of human therapeutic proteins and antibodies. It operates in the United States, Scotland, and Sweden. Viragen Inc. was founded in 1979 and is based in Plantation, Florida.